151 related articles for article (PubMed ID: 16379547)
61. No evidence of a role for cystatin B gene in juvenile myoclonic epilepsy.
Mumoli L; Tarantino P; Michelucci R; Bianchi A; Labate A; Franceschetti S; Marini C; Striano P; Gagliardi M; Ferlazzo E; Sofia V; Pennese L; Annesi G; Aguglia U; Guerrini R; Zara F; Gambardella A;
Epilepsia; 2015 Apr; 56(4):e40-3. PubMed ID: 25752200
[TBL] [Abstract][Full Text] [Related]
62. Protein therapy for Unverricht-Lundborg disease using cystatin B transduction by TAT-PTD. Is it that simple?
Andrade DM; Scherer SW; Minassian BA
Epilepsy Res; 2006 Nov; 72(1):75-9. PubMed ID: 16930946
[TBL] [Abstract][Full Text] [Related]
63. Clinical features and genetics of Unverricht-Lundborg disease.
Lehesjoki AE
Adv Neurol; 2002; 89():193-7. PubMed ID: 11968445
[No Abstract] [Full Text] [Related]
64. G to C transversion at a splice acceptor site causes exon skipping in the cystatin B gene.
Bespalova IN; Pranzatelli M; Burmeister M
Mutat Res; 1997 Sep; 382(1-2):67-74. PubMed ID: 9360639
[TBL] [Abstract][Full Text] [Related]
65. Gene-Expression Profiling Suggests Impaired Signaling via the Interferon Pathway in Cstb-/- Microglia.
Körber I; Katayama S; Einarsdottir E; Krjutškov K; Hakala P; Kere J; Lehesjoki AE; Joensuu T
PLoS One; 2016; 11(6):e0158195. PubMed ID: 27355630
[TBL] [Abstract][Full Text] [Related]
66. Mutations in the gene encoding cystatin B in progressive myoclonus epilepsy (EPM1).
Pennacchio LA; Lehesjoki AE; Stone NE; Willour VL; Virtaneva K; Miao J; D'Amato E; Ramirez L; Faham M; Koskiniemi M; Warrington JA; Norio R; de la Chapelle A; Cox DR; Myers RM
Science; 1996 Mar; 271(5256):1731-4. PubMed ID: 8596935
[TBL] [Abstract][Full Text] [Related]
67. Abnormal microglial activation in the Cstb(-/-) mouse, a model for progressive myoclonus epilepsy, EPM1.
Okuneva O; Körber I; Li Z; Tian L; Joensuu T; Kopra O; Lehesjoki AE
Glia; 2015 Mar; 63(3):400-11. PubMed ID: 25327891
[TBL] [Abstract][Full Text] [Related]
68. A new clinical and molecular form of Unverricht-Lundborg disease localized by homozygosity mapping.
Berkovic SF; Mazarib A; Walid S; Neufeld MY; Manelis J; Nevo Y; Korczyn AD; Yin J; Xiong L; Pandolfo M; Mulley JC; Wallace RH
Brain; 2005 Mar; 128(Pt 3):652-8. PubMed ID: 15634728
[TBL] [Abstract][Full Text] [Related]
69. [Unverricht-Lundborg disease manifesting tremulous myoclonus with rare convulsive seizures: a case report].
Kondo T; Yamakado H; Kawamata J; Tomimoto H; Hitomi T; Takahashi R; Ikeda A
Rinsho Shinkeigaku; 2009 Jan; 49(1):43-7. PubMed ID: 19227896
[TBL] [Abstract][Full Text] [Related]
70. Seizures, ataxia, and neuronal loss in cystatin B heterozygous mice.
Kaasik A; Kuum M; Aonurm A; Kalda A; Vaarmann A; Zharkovsky A
Epilepsia; 2007 Apr; 48(4):752-7. PubMed ID: 17319918
[TBL] [Abstract][Full Text] [Related]
71. Hyperostosis frontalis interna as a novel finding in Unverricht-Lundborg disease.
Korja M; Kaasinen V; Lamusuo S; Marttila RJ; Parkkola R
Neurology; 2007 Mar; 68(13):1077-8. PubMed ID: 17389316
[No Abstract] [Full Text] [Related]
72. Tetraplex formation by the progressive myoclonus epilepsy type-1 repeat: implications for instability in the repeat expansion diseases.
Saha T; Usdin K
FEBS Lett; 2001 Mar; 491(3):184-7. PubMed ID: 11240124
[TBL] [Abstract][Full Text] [Related]
73. Neuropathological changes in a mouse model of progressive myoclonus epilepsy: cystatin B deficiency and Unverricht-Lundborg disease.
Shannon P; Pennacchio LA; Houseweart MK; Minassian BA; Myers RM
J Neuropathol Exp Neurol; 2002 Dec; 61(12):1085-91. PubMed ID: 12484571
[TBL] [Abstract][Full Text] [Related]
74. Clinical features and genetics of progressive myoclonus epilepsy of the Univerricht-Lundborg type.
Lehesjoki AE; Koskiniemi M
Ann Med; 1998 Oct; 30(5):474-80. PubMed ID: 9814834
[TBL] [Abstract][Full Text] [Related]
75. The molecular genetic bases of the progressive myoclonus epilepsies.
Serratosa JM; Gardiner RM; Lehesjoki AE; Pennacchio LA; Myers RM
Adv Neurol; 1999; 79():383-98. PubMed ID: 10514828
[TBL] [Abstract][Full Text] [Related]
76. Early microglial activation precedes neuronal loss in the brain of the Cstb-/- mouse model of progressive myoclonus epilepsy, EPM1.
Tegelberg S; Kopra O; Joensuu T; Cooper JD; Lehesjoki AE
J Neuropathol Exp Neurol; 2012 Jan; 71(1):40-53. PubMed ID: 22157618
[TBL] [Abstract][Full Text] [Related]
77. Molecular diagnosis of fragile X syndrome using methylation sensitive techniques in a cohort of patients with intellectual disability.
Chaudhary AG; Hussein IR; Abuzenadah A; Gari M; Bassiouni R; Sogaty S; Lary S; Al-Quaiti M; Al Balwi M; Al Qahtani M
Pediatr Neurol; 2014 Apr; 50(4):368-76. PubMed ID: 24630283
[TBL] [Abstract][Full Text] [Related]
78. Severe neurodegeneration, progressive cerebral volume loss and diffuse hypomyelination associated with a homozygous frameshift mutation in CSTB.
O'Brien A; Marshall CR; Blaser S; Ray PN; Yoon G
Eur J Hum Genet; 2017 Jun; 25(6):775-778. PubMed ID: 28378817
[TBL] [Abstract][Full Text] [Related]
79. Sensitive detection of polyalanine expansions in PHOX2B by polymerase chain reaction using bisulfite-converted DNA.
Horiuchi H; Sasaki A; Osawa M; Kijima K; Ino Y; Matoba R; Hayasaka K
J Mol Diagn; 2005 Nov; 7(5):638-40. PubMed ID: 16258163
[TBL] [Abstract][Full Text] [Related]
80. Tandem repeat sequence variation as causative cis-eQTLs for protein-coding gene expression variation: the case of CSTB.
Borel C; Migliavacca E; Letourneau A; Gagnebin M; Béna F; Sailani MR; Dermitzakis ET; Sharp AJ; Antonarakis SE
Hum Mutat; 2012 Aug; 33(8):1302-9. PubMed ID: 22573514
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
